NCT06478927 Backline Treatment of Advanced Hepatocellular Carcinoma With Palbociclib Status RECRUITING Phase NA
NCT06478719 To Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization Status RECRUITING Phase PHASE1/PHASE2
NCT06478693 A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC Status RECRUITING Phase PHASE1
NCT06475287 HAIC Combined With TQB2450 and Anlotinib in Second-line Treatment of Advanced Hepatocellular Carcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06475118 Comparison of Serum Myokine Dosages and Imaging Methods in the Evaluation of Sarcopenia in Patients With Hepatocellular Carcinoma Status RECRUITING Phase NA
NCT06467799 Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-1 for High-risk Recurrent HCC Status RECRUITING Phase PHASE2
NCT06464380 Anti-cancer Potentiality of Saffron Against Hepatocellular Carcinoma Status NOT_YET_RECRUITING Phase PHASE4
NCT06463522 Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes Therapy in Patients With Hepatocellular Carcinoma Status RECRUITING Phase PHASE1/PHASE2
NCT06446154 Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT06435013 Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCC Status COMPLETED Phase N/A
NCT06434753 Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease. Status RECRUITING Phase PHASE3
NCT06423144 PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7 Status NOT_YET_RECRUITING Phase N/A
NCT06420791 The Dual Impact of Cirrhosis on Transplantation for Hepatocellular Carcinoma:a Two-center Retrospective Cohort Study in China Status COMPLETED Phase N/A
NCT06409507 Research and Application for New Clinical Diagnosis and Treatment System for HBV Related HCC Liver Transplantation Status COMPLETED Phase N/A
NCT06406634 Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT06405321 Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma Status RECRUITING Phase N/A
NCT06405061 Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT06400160 Clinical Trial of TB511 in Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06389422 Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis Status RECRUITING Phase PHASE2